Increased PKR and eIF2α in Muscle of Cancer Patients
Author Information
Author(s): Eley H L, Skipworth R J E, Deans D A C, Fearon K C H, Tisdale M J
Hypothesis
Are phosphorylated forms of PKR and eIF2α important in muscle wasting in cancer patients?
Conclusion
Phosphorylation of PKR may be a key initiator of muscle wasting in cancer patients.
Supporting Evidence
- Phosphorylation of PKR was significantly enhanced in muscle of cancer patients with weight loss.
- There was a linear relationship between phosphorylation of PKR and eIF2α.
- Myosin levels decreased as weight loss increased.
Takeaway
Cancer patients who are losing weight have higher levels of certain proteins in their muscles that may cause muscle loss.
Methodology
Muscle biopsies were taken from cancer patients and healthy controls to measure levels of phosphorylated PKR and eIF2α.
Limitations
The study only included patients with oesophago-gastric cancer and may not be generalizable to other types of cancer.
Participant Demographics
{"cancer_patients":{"number":29,"sex":{"male":13,"female":2},"age_range":"49-83"},"healthy_controls":{"number":10,"sex":{"male":9,"female":1},"age_range":null}}
Statistical Information
P-Value
0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website